rs807038
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_030929.5(KAZALD1):c.511+564G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.807 in 152,220 control chromosomes in the GnomAD database, including 49,821 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.81 ( 49821 hom., cov: 33)
Consequence
KAZALD1
NM_030929.5 intron
NM_030929.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.230
Publications
0 publications found
Genes affected
KAZALD1 (HGNC:25460): (Kazal type serine peptidase inhibitor domain 1) This gene encodes a secreted member of the insulin growth factor-binding protein (IGFBP) superfamily. The protein contains an insulin growth factor-binding domain in its N-terminal region, a Kazal-type serine protease inhibitor and follistatin-like domain in its central region, and an immunoglobulin-like domain in its C-terminal region. Studies of the mouse ortholog suggest that this protein may function in bone development and bone regeneration. This gene is hypomethylated and over-expressed in high-grade glioma compared to low-grade glioma, and thus the hypomethylated gene may be associated with cell proliferation and the shorter survival of patients with high-grade glioma. It is also one of numerous genes found to be deleted in a novel 5.54 Mb interstitial deletion, which is associated with multiple congenital anomalies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.853 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KAZALD1 | NM_030929.5 | c.511+564G>C | intron_variant | Intron 2 of 4 | ENST00000370200.6 | NP_112191.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KAZALD1 | ENST00000370200.6 | c.511+564G>C | intron_variant | Intron 2 of 4 | 1 | NM_030929.5 | ENSP00000359219.6 | |||
| KAZALD1 | ENST00000470106.1 | n.162-539G>C | intron_variant | Intron 2 of 2 | 3 | |||||
| KAZALD1 | ENST00000477267.1 | n.26+564G>C | intron_variant | Intron 1 of 4 | 5 | |||||
| KAZALD1 | ENST00000477979.5 | n.113-539G>C | intron_variant | Intron 1 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.807 AC: 122747AN: 152102Hom.: 49780 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
122747
AN:
152102
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.807 AC: 122838AN: 152220Hom.: 49821 Cov.: 33 AF XY: 0.799 AC XY: 59466AN XY: 74422 show subpopulations
GnomAD4 genome
AF:
AC:
122838
AN:
152220
Hom.:
Cov.:
33
AF XY:
AC XY:
59466
AN XY:
74422
show subpopulations
African (AFR)
AF:
AC:
35726
AN:
41526
American (AMR)
AF:
AC:
11647
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
2845
AN:
3472
East Asian (EAS)
AF:
AC:
3121
AN:
5162
South Asian (SAS)
AF:
AC:
3309
AN:
4822
European-Finnish (FIN)
AF:
AC:
8027
AN:
10604
Middle Eastern (MID)
AF:
AC:
242
AN:
294
European-Non Finnish (NFE)
AF:
AC:
55480
AN:
68018
Other (OTH)
AF:
AC:
1700
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1228
2456
3684
4912
6140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
876
1752
2628
3504
4380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2401
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.